LONDON - Foresight Ventures VCT plc, a venture capital trust, has published a supplementary prospectus and announced the appointment of a new director following a recent merger. The supplementary document, released today, amends the initial prospectus dated October 11, 2024, and addresses updates in net asset values and corrections of typographical errors.
The original prospectus detailed an offer for subscription launched on November 15, 2024, and included information on the merger with Thames Ventures VCT 2 plc, completed on the same date. The latest net asset values for both companies as of September 30 and November 15, 2024, revealed significant new factors, necessitating the supplementary prospectus under regulatory requirements.
The identified typographical errors involved a performance incentive scheme between Foresight Ventures VCT and its manager, Foresight Group LLP, which have now been corrected as they constituted a material mistake in the initial prospectus. The Financial Conduct Authority has received copies of the updated document, which is also accessible through the National Storage Mechanism and Foresight Group LLP's website.
In addition to the prospectus update, Dr. Andrew Mackintosh has been officially appointed as a director of Foresight Ventures VCT plc. This follows the merger with Thames Ventures VCT 2 plc, where Dr. Mackintosh also serves as a director. The company has confirmed that there is no further information required to be disclosed regarding Dr. Mackintosh's appointment under UK Listing Rules.
This announcement, based on a press release statement, comes as Foresight Ventures VCT continues to navigate the post-merger landscape and seeks to provide clear and accurate information to its investors and the market.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.